Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine
Eligible age
18–65 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this clinical trial is to learn if the behavioral treatment called Acceptance and Commitment Therapy (ACT) works to improve disability in adults with chronic migraine. The main questions it aims to answer are: Does the use of ACT added to usual treatment improve scores on questionnaires designed to measure daily functioning and activity? Does the use of ACT added to usual treatment improve scores on diaries designed to measure headache frequency and pain? Researchers will compare adding ACT to usual headache treatments to usual headache treatments without ACT. Participants who are selected for ACT will take 8 classes to learn ACT and then will practice it at home, in addition to their regular headache treatment. Those not selected will continue their regular headache treatment. Four times over the following year, participants will answer questions about their symptoms during each of four virtual visits. They will also keep a daily headache diary during the study
Sponsor: Brigham and Women's Hospital
You may qualify if…
- ✓ Willingness and ability to engage in the consent process
- ✓ Willingness to participate in the study, despite randomization outcome
- ✓ Availability for the duration of the study
- ✓ Diagnosis of chronic migraine followed at the Graham Headache Center
- ✓ Access to the necessary resources for participating in a technology-based intervention
You may not qualify if…
- ✕ Known major depression or other psychiatric condition
- ✕ Non-English speaking
- ✕ Secondary headache diagnosis
- ✕ Psychotherapy in the prior 18 months
- ✕ Any reason the provider feels would limit participant ability to learn or practice ACT
- ✕ Any previous experience with mindfulness or meditation approaches
Where it's recruiting
Boston
Source: ClinicalTrials.gov · NCT06795867 · last updated 2025-10-31